Literature DB >> 8433550

Renal tubular basement membrane and collagen type IV in diabetes mellitus.

F N Ziyadeh1.   

Abstract

The pathogenesis of the multiple structural lesions in diabetic nephropathy remains debated, and likely is multifactorial. The uniform thickening of the renal basement membranes lining the glomerular and tubular elements appears to be a consequence of the metabolic perturbations which are directly related to hyperglycemia. While most investigations have focused on the increased accumulation of extracellular matrix in the glomerular basement membrane and the mesangium, and their relation to derangements in glomerular function, little is known regarding the pathogenesis and the significance of the tubulointerstitial changes and the thickened tubular basement membrane (TBM). It is possible that these latter changes are causally related to the cellular hypertrophy of the renal tubular epithelium that lines the TBM. It has been postulated that in the earlier stages of the disease, hyperglycemia induces renal tubular hypertrophy and stimulates the synthesis of the various matrix components which are normal constituents of the TBM. Later, the structural composition of the TBM is susceptible to further modifications by non-enzymatic glycation, and this aberrant process may impart a relative resistance to matrix degradation leading to a slow turnover. In vitro investigations on murine proximal tubule cells in culture have provided evidence that elevated ambient glucose is a sufficient stimulus for cellular hypertrophy and increased biosynthesis of collagen type IV, the predominant constituent of TBM. High glucose levels increase steady-state collagen IV mRNA, partly due to transcriptional activation of cis-acting elements of the gene which are controlled by putative glucose-responsive trans-acting proteins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433550     DOI: 10.1038/ki.1993.19

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  RAGE mRNA expression in the diabetic mouse kidney.

Authors:  F N Ziyadeh; M P Cohen; J Guo; Y Jin
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

2.  Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice.

Authors:  Xiaohui Tong; Haijian Ma; Sarah Wambui Amadi; Lingman Ma; Guanzhong Wu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-06       Impact factor: 3.000

3.  Peroxidasin-mediated bromine enrichment of basement membranes.

Authors:  Cuiwen He; Wenxin Song; Thomas A Weston; Caitlyn Tran; Ira Kurtz; Jonathan E Zuckerman; Paul Guagliardo; Jeffrey H Miner; Sergey V Ivanov; Jeremy Bougoure; Billy G Hudson; Selene Colon; Paul A Voziyan; Gautam Bhave; Loren G Fong; Stephen G Young; Haibo Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

4.  Genistein protects female nonobese diabetic mice from developing type 1 diabetes when fed a soy- and alfalfa-free diet.

Authors:  Tai L Guo; Dori R Germolec; Jian Feng Zheng; Linda Kooistra; Wimolnut Auttachoat; Matthew J Smith; Kimber L White; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2014-04-08       Impact factor: 1.902

Review 5.  Mechanism of action of angiotensin-receptor blocking agents.

Authors:  H M Siragy; M Bedigian
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

6.  Role of the renin angiotensin system in diabetic nephropathy.

Authors:  Tanuj Chawla; Deepika Sharma; Archana Singh
Journal:  World J Diabetes       Date:  2010-11-15

7.  Binding of Amadori glucose-modified albumin by the monocytic cell line MonoMac 6 activates protein kinase C epsilon protein tyrosine kinases and the transcription factors AP-1 and NF-kappaB.

Authors:  R Salazar; R Brandt; S Krantz
Journal:  Glycoconj J       Date:  2001-10       Impact factor: 2.916

8.  Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy.

Authors:  Mehmet Kanter
Journal:  J Mol Histol       Date:  2009-05-31       Impact factor: 2.611

9.  Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.

Authors:  M P Cohen; K Sharma; Y Jin; E Hud; V Y Wu; J Tomaszewski; F N Ziyadeh
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

10.  Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.

Authors:  Hyo Soon Jeong; Kwan Kyu Park; Kwan Kyu Park; Sang Pyo Kim; In Jang Choi; In Kyu Lee; Hyun Chul Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.